Jain Global LLC Atossa Therapeutics, Inc. Transaction History
Jain Global LLC
- $19.5 Billion
- Q3 2025
A detailed history of Jain Global LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Jain Global LLC holds 16,707 shares of ATOS stock, worth $13,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,707
Previous 123,054
86.42%
Holding current value
$13,532
Previous $102,000
86.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATOS
# of Institutions
75Shares Held
26.8MCall Options Held
79.5KPut Options Held
98.8K-
Black Rock Inc. New York, NY9.2MShares$7.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.08MShares$4.92 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.95MShares$2.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.67MShares$1.35 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.55MShares$1.25 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $103M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...